Clorox (CLX)
NYSE: CLX
· Real-Time Price · USD
119.53
-2.64 (-2.16%)
At close: Aug 18, 2025, 3:59 PM
120.20
0.56%
After-hours: Aug 18, 2025, 06:07 PM EDT
Clorox Revenue Breakdown
| Period Ending | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2015 | Jun 30, 2014 | Jun 30, 2013 | Jun 30, 2012 | Jun 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health and Wellness Revenue | 2.7B | 2.48B | 2.53B | 2.69B | 2.98B | 2.75B | 1.87B | 1.96B | 1.96B | 1.79B | 1.71B | 1.69B | 1.68B | 1.61B |
| Health and Wellness Revenue Growth | +8.53% | -1.86% | -5.87% | -9.73% | +8.40% | +47.01% | -4.54% | -0.10% | +9.31% | +4.97% | +0.95% | +1.01% | +4.03% | n/a |
| Household Revenue | 2B | 1.95B | 2.1B | 1.98B | 1.98B | 1.79B | 970M | 1.03B | 1.01B | 1.09B | 1.17B | 1.22B | 1.2B | 1.12B |
| Household Revenue Growth | +2.62% | -7.05% | +5.75% | +0.15% | +10.36% | +85.05% | -5.64% | +1.78% | -7.08% | -7.09% | -3.94% | +1.58% | +7.25% | n/a |
| International Revenue | 1.06B | 1.16B | 1.18B | 1.18B | 1.16B | 1.02B | 1.26B | 1.08B | 1B | 950M | 936M | 929M | 901M | 883M |
| International Revenue Growth | -8.35% | -1.61% | +0.08% | +1.55% | +13.59% | -19.13% | +17.46% | +7.70% | +5.26% | +1.50% | +0.75% | +3.11% | +2.04% | n/a |
| Lifestyle Revenue | 1.3B | 1.27B | 1.34B | 1.25B | 1.22B | 1.15B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Lifestyle Revenue Growth | +2.20% | -4.71% | +6.78% | +2.87% | +5.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2015 | Jun 30, 2014 | Jun 30, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign Revenue | 1.02B | 5.96B | 6.24B | 5.95B | 6.21B | 996M | 5.28B | 5.13B | 5B | 4.61B | 1.13B | 1.18B |
| Foreign Revenue Growth | -82.81% | -4.51% | +4.81% | -4.12% | +523.19% | -81.14% | +2.84% | +2.68% | +8.51% | +309.69% | -4.26% | n/a |
| United States Revenue | 6.08B | n/a | n/a | n/a | n/a | 5.72B | n/a | n/a | n/a | n/a | 4.47B | 4.45B |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +0.40% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 296M | 474M | 471M | 482M | 534M | 516M | 508M | 441M | 540M | 517M | 438M | 422M | 451M | 386M | 408M | 418M | 484M | 437M | 456M | 417M | 493M | 453M | 350M | 348M | 384M | 377M | 356M | 351M | 374M | 358M | 337M | 338M | 394M | 362M | 325M | 328M | 417M | 350M | 317M | 309M | 372M | 330M |
| Selling, General, and Administrative Revenue Growth | -37.55% | +0.64% | -2.28% | -9.74% | +3.49% | +1.57% | +15.19% | -18.33% | +4.45% | +18.04% | +3.79% | -6.43% | +16.84% | -5.39% | -2.39% | -13.64% | +10.76% | -4.17% | +9.35% | -15.42% | +8.83% | +29.43% | +0.57% | -9.38% | +1.86% | +5.90% | +1.42% | -6.15% | +4.47% | +6.23% | -0.30% | -14.21% | +8.84% | +11.38% | -0.91% | -21.34% | +19.14% | +10.41% | +2.59% | -16.94% | +12.73% | n/a |
| Research and Development Revenue | 32M | 27M | 31M | 31M | 33M | 32M | 32M | 29M | 38M | 35M | 33M | 32M | 34M | 31M | 34M | 33M | 45M | 32M | 40M | 32M | 42M | 39M | 34M | 30M | 38M | 34M | 32M | 32M | 37M | 32M | 31M | 32M | 37M | 35M | 32M | 31M | 42M | 35M | 34M | 30M | 39M | 34M |
| Research and Development Revenue Growth | +18.52% | -12.90% | 0.00% | -6.06% | +3.12% | 0.00% | +10.34% | -23.68% | +8.57% | +6.06% | +3.12% | -5.88% | +9.68% | -8.82% | +3.03% | -26.67% | +40.62% | -20.00% | +25.00% | -23.81% | +7.69% | +14.71% | +13.33% | -21.05% | +11.76% | +6.25% | 0.00% | -13.51% | +15.62% | +3.23% | -3.12% | -13.51% | +5.71% | +9.38% | +3.23% | -26.19% | +20.00% | +2.94% | +13.33% | -23.08% | +14.71% | n/a |